Epidemiology and Prevention of Vaccine-Preventable Diseases


Watch as Donna Weaver, RN, a nurse educator, discuss immunization schedules, general recommendations, and vaccine safety.

In this video—the first of a four-part program—CDC experts Andrew Kroger, MD, MPH, and Donna Weaver, RN, discuss the most current recommendations for immunizations. Topics featured include immunization schedules, general recommendations, contraindications and precautions, adverse reactions and vaccine safety, and vaccine administration.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.